HIV and Hepatitis.com Coverage of the
15th Conference on Retroviruses and Opportunistic Infections (CROI 2008)
 February 3 - 6, 2008, Boston, MA
The material posted on HIV and Hepatitis.com about CROI 2008 is not approved
by nor is it a part of CROI 2008.

Circumcision Lowers Risk of Genital Herpes in Men, but Has Mixed Effects for Female Partners

By Liz Highleyman

The most exciting news in the field of HIV prevention research in recent years has been the demonstration that adult male circumcision reduced the rate of HIV infection by as much as 60 in high-prevalence countries in Africa.

At the 15th Conference on Retroviruses and Opportunistic Infections last week in Boston, conference vice-chair John Mellors, MD, of the University of Pittsburgh called this "the single most important finding in HIV prevention in the last decade, and arguably in the entire epidemic."

Researchers with the Makerere University/Johns Hopkins collaboration presented further good news about the beneficial effects of circumcision for men, but some worrisome results for their female partners.

Genital Infections in Men and Women

As previously reported, nearly 5000 men in Rakai, Uganda, who expressed an interest in circumcision were randomly assigned to undergo the procedure immediately or after a 2-year delay.

In the first analysis (abstract 28LB), investigators assessed whether circumcision would help prevent infection with herpes simplex type 2 (HSV-2, the usual cause of genital herpes) in men and vaginal infections in women. This analysis focused on about 1400 men each in the immediate circumcision and the delayed control arm who did not have HSV-2 at study entry. The men were followed for 24 months to determine the rate of HSV-2 acquisition.

In addition, about 800 wives of men in each group were followed for 12 months to assess the incidence of genitourinary disease (GUD), bacterial vaginosis (BV), and trichomonas.

Results

Among the men, about 7% in the immediate circumcision arm became infected with HSV-2, compared with 10% in the delayed control arm - a reduction of 25%.

The relative risk of HSV-2 infection was lower in the circumcision arm in all socio-demographic and behavioral subgroups.

PCR testing for HSV-1, HSV-2, Treponema pallidum (which causes syphilis), and Haemophilus ducreyi (which causes chancroid) identified a causal pathogen in more than one-third of genital ulcers, 90% of which was HSV-2.

Among the 62 men who acquired HIV during the trial, about 60% had either prior HSV-2 infection or simultaneous HIV and HSV-2 seroconversion.

Among women, the rate of genital infections was lower in the wives of men in the immediate circumcision arm compared with the control arm:

Symptomatic GUD: 25% reduction;

Trichomonas: 50% reduction;

Bacterial vaginosis: 20% reduction;

Severe BV: 60% reduction.

Among women with normal vaginal flora at enrollment, progression to BV was 20% less likely, and among women with BV at enrollment persistence was reduced by a similar amount, in wives of men in the immediate circumcision arm.

However, there were no differences in reported symptoms of vaginal discharge or dysuria (difficult or painful urination) in the 2 study arms.

"Male circumcision prevents HSV-2 acquisition in men and reduces rates of GUD, trichomonas, and BV in their female partners," the researchers concluded. "These effects of circumcision may influence the protective effect of circumcision on HIV acquisition."

Raised HIV Risk in Women?

Another analysis suggested that men who are HIV positive at the time of circumcision may be more likely to transmit HIV to their female partners if they resume sex before the wound is fully healed.

In this study (abstract 33LB), researchers looked at 1015 HIV positive men with a CD4 count above 350 cells/mm3 randomized to the immediate circumcision or delayed control groups. The 770 married men were asked to invite their spouses to participate; 566 did so, of whom 245 (43%) were HIV negative. Men were seen post-operatively and at 1, 6, 12, and 24 months; women were seen at 6, 12, and 24 months.

Results

In an intent-to-treat analysis that included 161 serodiscordant couples, the women's 24-month cumulative HIV incidence was about 14 per 100 person-years in the immediate circumcision arm versus about 9 per 100 person-years in the control arm.

This difference did not reach statistical significance (P = 0.42).

Women's incidence was highest in both arms in the 0-6 month follow-up interval (27 vs 18 per 100 person-years), declining during the following 6-24 months (6% vs 4% per 100 person-years).

In the immediate circumcision arm, the excess cases of HIV transmission in months 0-6 occurred among couples who resumed sexual intercourse more than 5 days prior to certified wound healing (29%) compared with couples who waited longer (10%).

Rates of bacterial vaginosis, vaginal discharge, dysuria, and genitourinary disease were comparable among wives in both study arms during follow-up.

Circumcision reduced the rate of GUD in circumcised compared with uncircumcised HIV positive men (about 10% vs about 16%).

The rate of circumcision-related moderate adverse events in HIV positive men was equivalent to that of HIV negative men in a parallel trial (about 3% in both).

There were no circumcision-related serious adverse events seen in the in HIV positive men.

About 70% of HIV positive men had complete wound healing by 30 days post-circumcision, compared with about 80% of HIV negative men.

Male circumcision was safe and reduced GUD in HIV positive men," the researchers concluded. However, they added, "There were no direct HIV benefits to women but, potentially, an increased risk of transmission with early resumption of sex."

Though full healing after circumcision usually occurs by 1 month, co-investigator Maria Wawer said men ideally should wait 6-8 weeks to be on the safe side, especially given the evidence that healing may be slower in HIV positive men.

Much remains to be learned about circumcision and HIV prevention. For example, it is unclear why rates of genital infections decreased in wives of circumcised men in the first of mostly HIV negative men but not the second study of HIV positive men.

Women's risk of acquiring HIV would be reduced if female partners of circumcised men have less genital ulcer disease, and if the overall proportion of HIV positive men in a population goes down. But it remains to be seen how these benefits would weigh against the potential higher risk of transmission due to early sex after circumcision of HIV positive men.

For men, it is not yet determined whether the reduced risk of acquiring HIV after circumcision is a direct effect of removing susceptible foreskin tissue or an indirect effect of reducing genital ulcer diseases such as herpes, which are known to facilitate HIV infection.

It is also not yet known how this new information about the effects of circumcision on genital ulcer disease and HIV transmission might apply to men who have sex with men, given that circumcision has not been shown to reduce the risk of HIV in low-prevalence settings such as the U.S.

Johns Hopkins University, Baltimore, MD; Makerere University, Kampala, Uganda; NIAID, NIH, Bethesda, MD; Rakai Health Science Program, Entebbe, Uganda.

2/12/08

References

A Tobian, D Serwadda, T Quinn, and others. Trial of Male Circumcision: Prevention of HSV-2 in Men and Vaginal Infections in Female Partners, Rakai, Uganda. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA. February 3-6, 2008. Abstract 28LB.

M Wawer, G Kigozi, D Serwadda, and others. Trial of Male Circumcision in HIV+ Men, Rakai, Uganda: Effects in HIV+ Men and in Women Partners. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA. February 3-6, 2008. Abstract 33LB.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 Google Custom Search